These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 5491517)

  • 21. [Use of lipoic acid and its amide in chronic liver diseases].
    Romanov VS
    Sov Med; 1971; 34(12):43-5. PubMed ID: 4948129
    [No Abstract]   [Full Text] [Related]  

  • 22. [Corticosteroid therapy in hepatic diseases].
    Mazzacca G
    Recenti Prog Med; 1967 Jul; 43(1):51-70. PubMed ID: 4302862
    [No Abstract]   [Full Text] [Related]  

  • 23. [Long term therapy of chronic progressive (aggressive) hepatitis using a combination of imuran and prednisone].
    Schimmelpfennig W; Wagner K; Theuer D; Schneider G; Hecht A; Schimmelpfennig R
    Dtsch Gesundheitsw; 1971 Oct; 26(42):1965-71. PubMed ID: 5004132
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapy of liver diseases, possibilities and problems].
    Renger F
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):9-13. PubMed ID: 4100481
    [No Abstract]   [Full Text] [Related]  

  • 25. [Side-effects of glucocorticoids in liver therapy].
    Möller E; Brinkmann W; Weber O; Wildhirt E
    Dtsch Med Wochenschr; 1969 Jun; 94(26):1371-3 passim. PubMed ID: 5787349
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effects of treatment with nucleotides and aspartic acid in chronic liver diseases].
    Iencica R
    Med Interna (Bucur); 1972 Dec; 24(12):1449-53. PubMed ID: 4655566
    [No Abstract]   [Full Text] [Related]  

  • 27. [Use of a titrated extract of Centella asiatica in chronic hepatic disorders (author's transl)].
    Darnis F; Orcel L; de Saint-Maur PP; Mamou P
    Sem Hop; 1979 Nov 8-15; 55(37-38):1749-50. PubMed ID: 230597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Apropos of the indications for anabolic steroids in the treatment of chronic hepatic lesions].
    Blahniková L; Horký J
    Gastroenterologia; 1967; 107(6):354-9. PubMed ID: 6052562
    [No Abstract]   [Full Text] [Related]  

  • 29. [Silymarin and various problems of current therapy of chronic liver diseases].
    Fassati P; Fassati M
    Cas Lek Cesk; 1973; 112(28):865-9. PubMed ID: 4720441
    [No Abstract]   [Full Text] [Related]  

  • 30. [The effect of furosemide on the liver function].
    Pickert H; Müller K; Henning H
    Ther Ggw; 1966 Feb; 105(2):250-4. PubMed ID: 5915868
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prednisolone therapy of patients with chronic hepatitis and cirrhosis of the liver].
    Vasil'eva LN
    Klin Med (Mosk); 1966 May; 44(5):42-8. PubMed ID: 5990929
    [No Abstract]   [Full Text] [Related]  

  • 32. [Anabolic steroids and liver diseases].
    Wewalka F
    Wien Med Wochenschr; 1967 Mar; 117(12):293-9. PubMed ID: 4871957
    [No Abstract]   [Full Text] [Related]  

  • 33. [Observations on the treatment of chronic inflammatory liver diseases with the preparation Hepasteril B comp].
    Busse K; Otremba P
    Soins; 1970; 15(7):2608-13. PubMed ID: 4918343
    [No Abstract]   [Full Text] [Related]  

  • 34. [Further clinical experiences with ornithine aspartate in liver diseases].
    Wotzka R; Weber D
    Ther Ggw; 1972 Mar; 111(3):400-12. PubMed ID: 5024593
    [No Abstract]   [Full Text] [Related]  

  • 35. [Indications, method and effectiveness of immunosuppressive treatment in chronic active hepatopathies. I. Changes in the general dynamics of the disease. II. Slowing-down of the chronicization process].
    Nicolaescu T; Stoiculescu P; Bittman E; Bordeianu A; Gheorghe N; Pintilescu V; Metz L
    Med Interna (Bucur); 1974 Apr; 26(4):453-64. PubMed ID: 4839352
    [No Abstract]   [Full Text] [Related]  

  • 36. [Long-term therapy of chronic hepatitis].
    De Groote J; Maes H; Vandenbroucke J
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):15-7. PubMed ID: 5501420
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hepagrisevit forte in chronic liver diseases].
    Kollatz E; Kramer A; Schopper W; Siede W
    Med Klin; 1965 Dec; 60(50):2032-5. PubMed ID: 5331151
    [No Abstract]   [Full Text] [Related]  

  • 38. [Recent findings in drug treatment of liver disease patients with ornithine-carbamyl-transferase (OCT). Personal experience].
    Alvisi V; Tralli M; Tampieri ML; Lo Ponte A; D'Ambrosi A
    Minerva Dietol Gastroenterol; 1982; 28(4):335-40. PubMed ID: 7167246
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical and biological effectiveness of citiolone and importance of its contribution in hepatic therapeutics].
    Duché G
    Therapeutique; 1970 Dec; 46(10):1037-41. PubMed ID: 5511931
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hepatoprotective drugs. Clinical results of the use of a sulfhydryl-methylating preparation].
    Rapino P; Marulli R; Rapex G; Della Lunga S; Sabatino P
    Minerva Med; 1982 Oct; 73(40):2853-60. PubMed ID: 7133498
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.